コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 sion improvement in the presence of retained night vision.
2 e retina, illuminating the role of GPR179 in night vision.
3 five patients had life-long, extremely poor night vision.
4 n allows many patients to adapt to their new night vision.
5 photomultipliers, and image intensifiers for night vision.
6 nd human vision, including thermal image and night vision.
7 nal diseases with the common feature of poor night vision.
8 cannabinoid CB(1) receptors may help improve night vision.
9 t detection, prey capture, color vision, and night vision.
10 haracterized by nonprogressive impairment of night vision, absence of the electroretinogram (ERG) b-w
11 ntiated the effect of vitamin A in restoring night vision among night-blind pregnant women with low i
12 S-1 AC mediates long-range inhibition during night vision and is a major element of the RB pathway.
13 eye), photophobia, and nyctalopia (impaired night vision); and (iii) a prospective semi-structured t
15 ificant visual function deficits in reading, night vision, and dark adaptation, and produce dense, ir
16 d photoreceptor dysfunction leads to loss of night vision, and is followed by secondary cone photorec
17 of rod signals from Aii cells to ON CBCs for night vision, and we find that the uneven distribution o
20 data rate wireless communications, security, night-vision, biomedical or video-imaging and gas sensin
21 therapy can result in modest improvements in night vision, but knowledge of its efficacy in humans is
29 , are useful for various applications, e.g., night-vision devices, optical communication, and medical
30 ligible if they reported experiencing severe night vision difficulty that was not eliminated by dista
32 Many patients voice concerns regarding poor night vision, even when they see 20/20 or better in the
35 t the realistic therapeutic goal of improved night vision for retinal regions specifically preselecte
40 logically important for applications such as night vision, imaging, sensing, and thermal metrology.
41 pigmentosa, in which patients typically lose night vision in adolescence, side vision in young adulth
45 hors are being widely used as self-sustained night-vision materials because of their sufficiently str
46 rioration of central vision and subsequently night vision, mild photophobia, and moderate to high myo
47 bipolar cell (CBC) network are essential for night vision, modulation of day vision, and contribute t
50 y of daily zinc supplementation in restoring night vision of pregnant women who developed night blind
53 of RGC types receives direct input from the night-vision pathway, independent from OFF bipolar cell
54 ery, considerations such as preexisting AMD, night vision problems or sleep problems may be considere
57 ct of Vision Impairment (IVI-28) and 10-item Night Vision Questionnaire (NVQ-10) were administered at
58 n volume in the study or non-study eyes, and Night Vision Questionnaire and Impact of Vision Impairme
59 d participant-reported outcomes based on the Night Vision Questionnaire and Impact of Vision Impairme
61 mol/L were 4 times more likely to have their night vision restored (95% CI: 1.1, 17.3) than were wome
62 ly prescribed for severe acne but can impair night vision shortly after the beginning of therapy.
64 This type of technology could be useful for night-vision surveillance, endoscopic imaging, and other
65 ent materials have potential applications in night-vision surveillance, solar energy utilization and
69 le applications such as in automobile seats, night-vision systems, and electrical-enclosure cooling.
71 le rescue of electroretinography signals and night vision up to 1 y, paving the way for clinical tria
72 As rod photoreceptors are responsible for night vision, we administered isotretinoin to rats to le